Extract notice to the Minister
ACT Buprenorphine/Naloxone
Common name / Subject : buprénorphine/naloxone
Name of the manufacturer : ActavisPhm
Form : Co. S-Ling.
Dosage : 2 mg - 0,5 mg, 8 mg - 2 mg
Name of the manufacturer : ActavisPhm
Form : Co. S-Ling.
Dosage : 2 mg - 0,5 mg, 8 mg - 2 mg
Indication :
INESSS' Recommendation
Avis d'inscription aux listes des médicaments
Minister's decisions
Inscrire aux listes des médicaments
Evaluation published on April 12, 2018